Pact x Symbe

‍

We are thrilled to announce our investment in Symbe! This innovative platform is set to revolutionize the way companies sell and procure, and it’s all thanks to the visionary team behind it. Martin Blinder, Thomas Laurbjerg, and Xavier Wilders, seasoned founders from the Healthtech industry, have combined their expertise to create a solution that tackles a critical pain point in the sales process.

‍

Martin’s experience during his last startup was eye-opening. Despite having a product that drove patient outcomes and saved healthcare costs, his sales team struggled to effectively communicate the value to their clients in a scalable way. The missing piece? A compelling and clear quantitative discussion of outcomes delivered through a business case. This realization led to the birth of Symbe, a platform that automates the creation of powerful business cases by merging quantitative and qualitative storytelling.

‍

Why Symbe?

‍

Symbe’s AI-powered platform is a game-changer for industries characterized by lengthy sales cycles, multiple stakeholders, and a focus on outcomes. By streamlining the sales and procurement processes and emphasizing outcome-based success, Symbe facilitates collaboration between buyer and seller, fostering an ongoing post-sale relationship that tracks and enhances effectiveness and value creation over time. The potential impact of Symbe’s approach, particularly in the healthcare sector, is immense — it has the power to drive down costs while improving patient outcomes, aligning perfectly with Pact’s Betterment investment theme.

‍

What sets Symbe apart is not just its cutting-edge technology, but the exceptional team behind it. Martin, a serial entrepreneur with a proven track record, brings his deep understanding of the health sector to the table. Xavier’s technical brilliance and Thomas’ commercial acumen complete the trifecta, enabling Symbe to rapidly build out its platform and execute its go-to-market strategy with precision.

‍

Symbe’s reach extends across various B2B and B2B SaaS verticals. While generic sales enablement tools have often fallen short in complex sales environments, Symbe’s solution enables each industry to tailor business cases, their unique language, and outcomes to their needs, resonating with the unique dynamics of buyers and sellers alike.

‍

Looking Ahead

‍

As early-stage investors, we at Pact are thrilled to be part of Symbe’s journey, alongside an impressive group of investors including Concept Ventures, Notion Capital, and Nodes Syndicate. The calibre of this investment syndicate is a testament to the strength of Symbe’s team and the transformative potential of their platform.

‍

Looking ahead, we see a bright future for Symbe and its alignment with our Betterment theme. The downstream benefits and impact on consumers and stakeholders within a range of high-impact sectors, including healthcare delivery have the potential to be truly transformative, driving better patient outcomes and efficiency gains across the system.

‍

We are honoured to support Martin, Thomas, Xavier, and the entire Symbe team as they embark on this exciting journey. With their vision, expertise, and unwavering commitment to driving positive change, we are confident that Symbe will make a lasting impact on the business world and beyond.

‍

‍